VMRD Offers Novel Non-infectious Positive Control for RT-QuIC Testing

Are you feeling the strain of high-maintenance clients, compassion fatigue, and relentless stress? Join us for a webinar tailored to address

You asked, we answered. Fun facts about VMRD SAA!

Horse Vets work in all parts of the world, with all types of Equids:

It's every equine vet's favorite time of year - and I don't mean colic season!

Come visit us at booth #201/300 to meet with our team, including Sandy Clark, VMRD’s Molecular Product Manager, JJ McCallie

We are very excited to attend the 2022 Leman Swine Conference! We are attending this meeting as vendors for the first time this year...

VMRD is proud to announce the addition of Nucleic Acid Extraction Kits to its Molecular Product Line this Spring.

In this continuing feature, we catch up with Dr. Christopher Boutros from Waller Equine Hospital in Waller, TX.

Serum amyloid A (SAA) testing is a valuable tool for equine practitioners, whether they work in ambulatory practice or a referral hospital.

In this feature, we catch up with Dr. Kelly Torrisi, owner of Auburn Equine in Auburn, CA. Dr. Torrisi’s clinic employs 3 vets as well as 4

Foals are highly vulnerable and delicate compared to adult horses, making timely identification of disease particularly important for early

With normal conception and pregnancy, SAA level in broodmares is comparable to that in other healthy horses.

Colic can be one of the most rewarding and the most frustrating problems in equine medicine.

Watch and learn how to run VMRD's point-of-care lateral flow test for equine serum amyloid A (SAA) for horse-side results!

Routine equine health exams and biosecurity strategies utilize screening methods to detect underlying performance-limiting issues and potent

Early and accurate detection of septic arthritis/synovitis is critical to minimize damage to cartilage and other structures that can ultimat

To build on the internal validation performed by VMRD, our Serum Amyloid A (SAA) test was independently evaluated by at UC Davis.

To avoid unexpected SAA results it is critical to understand basic SAA biology and interpret results in light of other clinical data.

The dynamic nature of SAA makes it an ideal marker for monitoring progression or resolution of illness, including response to treatment.